“Twenty-Four Vs. Fourty-Eight Weeks of Re-Therapy With Interferon Alpha 2b and Ribavirin in Interferon Alpha Monotherapy Relapsers With Chronic Hepatitis C”. Swiss Medical Weekly 133, no. 3334 (August 23, 2003): 455–460. Accessed January 10, 2026. https://www.smw.ch/index.php/smw/article/view/299.